"Urology Associates is a Urology clinic that offers exceptional and innovative urologic care to the Denver metro area and our home state of Colorado. As we’ve grown, we have taken great care to find physicians who are equally committed to the art of medicine and the best in patient care."

During the past decade, Urology Associate PC' conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 9 clinical trials were completed, i.e. on average, 180% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Urology Associate PC'" #1 sponsor was "Ferring Pharmaceuticals" with 8 trials, followed by "Abbott" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Active Biotech AB" with 1 trials sponsored and "Allergan" with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Urology Associate PC'" #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator and "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Urology Associate PC'" are "Prostate Cancer" (11 trials), "Bladder Cancer" (2 trials), "Nocturia" (2 trials), "Urinary Incontinence" (2 trials) and "Benign Prostatic Hyperplasia (BPH)" (1 trials). Many other conditions were trialed in "Urology Associate PC'" in a lesser frequency.

Most popular intervention types in "Urology Associate PC'" are "Drug" (21 trials), "Device" (3 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Degarelix" (5 trials), "Atrasentan" (2 trials), "ABR-215050, tasquinimod" (1 trials) and "AQUABEAM System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Urology Associate PC'" are 17 trials for "Male" genders, 7 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Urology Associate PC'". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Urology Associate PC', 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Urology Associate PC', 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 2 trials that are defined as “Not Applicable".

Urology Associate PC' has several departments that took part in Clinical trials: "Urology Associates Research" - 5 trials